|
The Indian Council of Medical Research (ICMR) has shortlisted three companies namely Udyog Yantra Technologies Pvt Ltd, LVP Eye Innovations, Hyderabad, and Evelabs Technologies Pvt Ltd, Kollam under Accelerating Medical Device and Diagnostics Product Development and Scale-up under “Product Ignition & Development Enabler (mPRiDE) programme” to accelerate commercialisation of medical devices for public use.
The mPRiDE scheme will accelerate medical device product development, scale-up and commercialization by supporting medical device companies. The companies which have extensive experience and demonstrated capabilities can develop an enabling ecosystem to accelerate product deployment for societal impact.
Subject to the terms and conditions of an agreement, ICMR- Medical Device and Diagnostics Mission Secretariat (MDMS) shall support indigenous development, scale-up and pilots of Make-in-India manufacturing of critical medical devices and diagnostic products. Based on the recommendations of the Expert Committee the applications for manufacturing Make In India products in following areas have been duly considered for extending support for Chronic Obstructive Pulmonary Disorders (COPD), maternal, child healthcare and nutrition and Remote Monitoring Devices.
ICMR, New Delhi is the apex body in India for the formulation, coordination and promotion of biomedical research.
The Indian Medical device market is currently valued at USD 11.2 billion and is experiencing a growth rate of 15% CAGR and is poised to be USD 50 billion by 2025. India is dependent on imports for its medical device needs with about 80% of medical devices being imported.
In view of the huge import dependency and long technology development cycle of medical devices, there is an urgent need for providing holistic support across the medical device development and commercialization cycle including R&D, scale-up, validation, regulatory compliance and market access.
ICMR has established MDMS at ICMR headquarters with a vision to support and catalyze research, development and indigenous manufacturing of cost-effective medical devices to strengthen the health care sector in India and reduce import dependency through a Mission mode consortia approach.
MDMS will incentivize and motivate local manufacturing in India and provide holistic support to the technologies/products nearing commercialization. The medical device technologies at an advanced stage of development will be supported through this programme.
The evaluation of proposals included following criteria at each step of selection like technical rigor, national/societal impact, frugality, stage of product development, experience and track record of the applicant and readiness for product deployment at scale funding mechanism
The funding support under the present scheme is in the form of grant-in-aid. Extent of funding is up to Rs. 1.5 crore based on merit. The fund allocation is milestone based and shall be released in installments based on review of the milestones achieved.
|